The Finbloom Lab at the University of British Columbia seeks a full‑time Postdoctoral Research Fellow to work on a CIHR‑funded project developing bacterial therapeutics. The role involves designing and executing experiments in bacterial synthetic biology, genetic engineering, and in vivo mouse models of inflammatory bowel disease. The fellow will analyze data, contribute to manuscripts and grants, present findings, and mentor students. A PhD in a relevant field completed within five years, strong publication record, and expertise in bacterial engineering and molecular biology are required. The position offers a salary of $60,000 CAD per year plus comprehensive benefits, a one‑year contract renewable until April 2028, and a rolling application deadline of 28 February 2027.
| Department | Finbloom Lab, Faculty of Pharmaceutical Sciences |
| Position Type | Postdoctoral Research Fellow |
| Discipline | Pharmaceutical Sciences |
| Research Area | Bacterial synthetic biology and biomaterials for therapeutic delivery |
| Degree Required | PhD |
| Experience | PhD completed within 5 years prior to start date |
| Salary | $60,000 CAD per year + comprehensive benefits package |
| Funding | CIHR-funded |
| Contract Duration | 1 year, renewable until April 30, 2028 |
| Deadline | 2027-02-28 |
| Required Documents | Cover letter (max 2 pages), Curriculum Vitae (max 5 pages), Contact information for at least 2 references |
| Employer Address | UBC Vancouver Campus, Vancouver, BC, Canada |
| Employer Contact | [email protected] |
The project focuses on developing and delivering bacterial therapeutics by engineering synthetic biology platforms, creating biomaterial interfaces, and testing engineered strains in murine models of inflammatory bowel disease and bacterial infection. The aim is to advance nanomaterial‑bacterial interactions for improved human health outcomes.
Applicants who have earned a PhD in Microbiology, Cell and Molecular Biology, Bioengineering or a related discipline within the past five years, possess a strong first‑author publication record, and have demonstrated expertise in bacterial synthetic biology, genome engineering (especially E. coli), molecular biology techniques, and mouse disease models are encouraged to apply. Excellent communication skills and the ability to mentor students are also essential.
The Finbloom Lab, part of the Faculty of Pharmaceutical Sciences at UBC, designs nanomaterials that interact with bacterial communities to advance human health, focusing on bacterial therapeutics and drug delivery innovations.
$60,000 CAD per year plus comprehensive benefits.
February 28, 2027.
Contact information for at least two references must be provided.
This listing is summarised from the official advertisement. Always confirm the details, including the closing date, on the employer's own site before applying.
UpperCareers
Search 420+ open postdoc, PhD, assistant professor positions
Filter by field, country and institution — every vacancy links straight to the employer.
Browse all positions →